NPS Pharmaceuticals, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, reported its results for the third quarter.

“We are excited by the continued success of the Gattex launch in the U.S.,” said Francois Nader, MD, president and chief executive officer of NPS Pharmaceuticals.

Help employers find you! Check out all the jobs and post your resume.